DOC Q1 2026 Earnings Call Summary

Healthpeak Properties, Inc. (DOC) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

FFO as Adjusted: Reported at $0.45 per share.
Net Debt-to-EBITDA: Stood at 5.4x.
Dividends Paid: Over $200 million, yielding an annualized 7.5%.
Stock Buyback: $100 million repurchased in April at an FFO yield exceeding 10%.
Senior Housing Performance: Janus Living reported 35% revenue growth and 42% adjusted EBITDA growth.

2. Strategic Updates and Business Highlights

Acquisitions: Completed $700 million in acquisitions prior to the IPO of the senior housing business, maintaining exposure to senior housing despite selling 18% of the business.
Leasing Activity: Achieved 62,000 square feet of signed leases and letters of intent at the Gateway campus, with an additional 113,000 square feet in active proposals.
Outpatient Medical: Continued strong fundamentals with 5.4% cash re-leasing spreads on renewals and 91% total occupancy.
Joint Venture with Blackstone: Closed a recapitalization of a fully occupied outpatient portfolio at a 6.1% cash cap rate, raising $170 million in proceeds.

3. Forward Guidance and Outlook

2026 Earnings Guidance: Increased to a range of $1.71 to $1.75 per share.
Occupancy Expectations: Anticipate total occupancy in life sciences to increase by at least 100 basis points by year-end 2026.
IPO Impact: The Janus Living IPO is expected to be earnings neutral in 2026 but accretive in 2027 as cash proceeds are deployed into acquisitions.

4. Bad News, Challenges, or Points of Concern

Interest Expense Increase: Expected to rise by $20 million, alongside a $5 million increase in G&A expenses.
Market Pressures: Concerns regarding potential downward pressure on lab rents due to high vacancy rates in the broader market.
Future Uncertainty: While the leasing pipeline is strong, there is caution regarding the timing of opportunistic investments in life sciences, with a focus on disciplined capital allocation.

5. Notable Q&A Insights

Life Science Portfolio: Management expressed optimism about the leasing pipeline and tenant activity, noting that decisions are being made more quickly compared to previous periods.
Market Differentiation: Healthpeak's concentrated strategy in prime markets is seen as a competitive advantage, contrasting with peers facing declining occupancy.
Leasing Economics: Continued strong re-leasing spreads and modest leasing costs are expected to drive earnings growth, although management remains cautious about the overall market dynamics.

Overall, Healthpeak Properties demonstrated strong operational execution in Q1 2026, with positive momentum in leasing and strategic acquisitions, while also navigating challenges related to rising costs and market pressures.

DOC — Healthpeak Properties, Inc.